Form 8-K - Current report:
SEC Accession No. 0001214659-21-010230
Filing Date
2021-10-05
Accepted
2021-10-05 16:05:36
Documents
12
Period of Report
2021-09-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 m1032108k.htm   iXBRL 8-K 31637
  Complete submission text file 0001214659-21-010230.txt   203651

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE hgen-20210930.xsd EX-101.SCH 3001
3 XBRL LABEL FILE hgen-20210930_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE hgen-20210930_pre.xml EX-101.PRE 22343
5 EXTRACTED XBRL INSTANCE DOCUMENT m1032108k_htm.xml XML 3574
Mailing Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010
Business Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010 650.243.3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

EIN.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35798 | Film No.: 211306654
SIC: 2834 Pharmaceutical Preparations